glp-1 obesity drug news today 2025 Market Trends and Global Forecasts Report 2025: A What the Obesity Drugmakers Expect

The new class of weight-loss medications are hailed as game-changing wonder drugs, but just how safe and effective are they

Learn about the Ozempic blindness lawsuit, including NAION and other vision problems, and read about the study linking semaglutide use to severe eye problems.

Tirzepatide displayed an unprecedented glucose and body weight lowering potential, presenting also with the ability to increase insulin sensitivity, reduce systolic blood pressure and inflammation and ameliorate dyslipidemia, particularly by reducing triglycerides levels

This product is not intended to diagnose, treat, cure, or prevent any disease